Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * the patient is of age (at least 18 years). * sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. * relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. * the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

inclusion criteria: * the patient is of age (at least 18 years). * sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. * relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. * the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

Aug. 23, 2021, 7 p.m. usa

inclusion criteria: - the patient is of age (at least 18 years). - sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. - relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. - the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

inclusion criteria: - the patient is of age (at least 18 years). - sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. - relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. - the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

Feb. 16, 2021, 12:31 a.m. usa

inclusion criteria: - sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. - relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. - the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.

inclusion criteria: - sars-cov-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days. - relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract. - the patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.